Molecular Pharmacology

Papers
(The median citation count of Molecular Pharmacology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Expression of concern: “Adelmidrol, a Palmitoylethanolamide Analogue, as a New PharmacologicalTreatment for the Management of Inflammatory Bowel Disease” [Mol. Pharmacol. 2016; 90: 549-561] by Cordaro53
UCM-A86 is a selective positive allosteric modulator of GluN1/GluN3 NMDA receptors45
In Vitro Pharmacological Profile of KW-6356, a Novel Adenosine A2A Receptor Antagonist/Inverse Agonist41
A 19F-qNMR-Guided Mathematical Model for G Protein-Coupled Receptor Signaling41
Enhancing remyelination in multiple sclerosis via M1 muscarinic acetylcholine receptor40
Fat traffic control: S-acylation in axonal transport39
Simplified Method for Kinetic and Thermodynamic Screening of Cardiotonic Steroids through the K+-Dependent Phosphatase Activity of Na+/K+-ATPase with Chromogenic pNPP Substrate32
Structural Basis for the Allosteric Inhibition of Hypoxia-Inducible Factor 2 by Belzutifan28
Editorial Board23
Isoprenaline shows unique kinase dependencies in stimulating β1AR–β-arrestin2 interaction compared to endogenous catecholamines19
Editorial Board19
Development of a Novel Assay for Direct Assessment of Selective Amylin Receptor Activation Reveals Novel Differences in Behavior of Selective and Nonselective Peptide Agonists18
Regulation of organic anion transporting polypeptide 1B1 transport function by concurrent phosphorylation and lysine-acetylation: A novel posttranslational regulation mechanism17
Mechanism-based inactivation of human aldehyde oxidase by erlotinib: Mechanistic insights from structural analogs and molecular docking17
Identification of potent and selective small molecule TALK-1 inhibitors that promote β-cell function16
Binding affinities for histamine receptors 1 to 4: Systematic comparison of ligands from the Psychoactive Drug Screening Program Ki database and International Union of Basic and Clinical Pharmacology/16
Molecular pharmacology of mGlu7/8 heterodimers reveals unique properties of orthosteric agonists and positive allosteric modulators16
Thermogenic Modulation of Adipose Depots: A Perspective on Possible Therapeutic Intervention with Early Cardiorenal Complications of Metabolic Impairment15
Cholesterol residence time drives regulation of the G protein-coupled cholecystokinin receptor15
Local protein kinase A signaling pathologies in the endocrine system15
Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation14
Discovery of RGS2-FBXO44 interaction inhibitors using a cell-based NanoBit assay14
Resveratrol Binds Nuclear Receptor 4A1 (NR4A1) and Acts as an NR4A1 Antagonist in Lung Cancer Cells14
The Emerging Structural Pharmacology of ATP-Sensitive Potassium Channels14
Pore Opening, Not Voltage Sensor Movement, Underpins the Voltage-Dependence of Facilitation by a hERG Blocker13
St. John’s Wort Formulations Induce Rat CYP3A23-3A1 Independent of Their Hyperforin Content13
Research approaches for exploring the hidden conversations of G protein-coupled receptor transactivation13
6,7-Dichloro-1H-indole-2,3-dione-3-oxime functions as a superagonist for the intermediate-conductance Ca2+-activated K+ channel KCa3.113
Corrigendum to “Antitumor Effects of Dehydroxymethylepoxyquinomicin, a Novel Nuclear Factor-κB Inhibitor, in Human Liver Cancer Cells Are Mediated through a Reactive Oxygen Species-Dependent Mechanism13
Table of Contents12
Editorial Board12
A brief history of nerve action potentials after 160012
Corticosterone stimulates synthesis of 2-arachidonoylglycerol via putative membrane-bound glucocorticoid receptors and inhibits GABA release via CB1 cannabinoid receptors in the ventrolateral periaque12
BAY58-2667 Activates Different Soluble Guanylyl Cyclase Species by Distinct Mechanisms that Indicate Its Principal Target in Cells is the Heme-Free Soluble Guanylyl Cyclase-Heat Shock Protein 90 Compl12
Englerin A Inhibits T-Type Voltage-Gated Calcium Channels at Low Micromolar Concentrations12
Emerging roles of ubiquitin-specific proteases in the cardiovascular system12
Role of HNF4A-AS1/HNRNPC-mediated HNF4A ubiquitination protection against ritonavir-induced hepatotoxicity12
Differential RELA and GR recruitment to the BIRC3/BIRC2 locus: Molecular insight as to combinatorial regulation by proinflammatory cytokines and glucocorticoid12
ROLES OF THE PHOSPHORYLATION SITES OF DISTINCT α1A-ADRENERGIC RECEPTOR DOMAINS12
Distinctive patterns of G protein coupling induced by the structurally similar 5-HT2A receptor ligands ketanserin and altanserin in human prefrontal cortex11
Gα Protein Signaling Bias at Serotonin 1A Receptor11
Rational design of biased G protein-coupled receptor agonists11
Correction to “Sulforaphane Suppresses Polycomb Group Protein Level via a Proteasome-Dependent Mechanism in Skin Cancer Cells”11
EP4 Receptor Conformation Sensor Suited for Ligand Screening and Imaging of Extracellular Prostaglandins11
Correction to “A Brief Overview of the Toxic Sphingomyelinase Ds of Brown Recluse Spider Venom and Other Organisms and Simple Methods To Detect Production of Its Signature Cyclic Ceramide Phosphate”11
Table of Contents11
Corrigendum to “A subunit-selective negative allosteric modulator of GluN1/GluN3A glycine-activated receptor” [Molecular Pharmacology 108 (2026) 100104]11
Discovery and In Vitro Characterization of BAY 2686013, an Allosteric Small Molecule Antagonist of the Human Pituitary Adenylate Cyclase-Activating Polypeptide Receptor11
Modulation of Kv7 Channel Currents by Echinocystic Acid11
Commentary on the fourth Transatlantic G Protein-Coupled Receptor Symposium for early-career investigators11
Contents10
The β2 adrenergic receptor cross-linked interactome identifies 14-3-3 proteins as regulating the availability of signaling-competent receptors10
Editorial Board10
Repurposing lapatinib as a triple antagonist of chemokine receptors 3, 4, and 510
The effects of hippocampal miR-34c-5p on the age-related discrepancies in susceptibility to traumatic stress in the post-traumatic stress disorder mice model9
Editorial Board9
Corrigendum to “Novel Thiosemicarbazones Inhibit Lysine-Rich Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) Coisolated (LYRIC) and the LYRIC-Induced Epithelial- Mesenchymal Transi9
Expression of concern: “Caveolin-1 and Lipid Microdomains Regulate Gs Trafficking and Attenuate Gs/Adenylyl Cyclase Signaling” [Molecular Pharmacology, Volume 76, Issue 5, November 2009, Pages 1082-109
Editorial Board8
Structural and molecular determinants of glutamate transporter allosteric modulators8
Heterogeneous nuclear ribonucleoprotein A/B drives gastric cancer and epithelial-mesenchymal transition via the Akt-GSK3β-Wnt pathway8
Editorial Board8
Going Rogue: Mechanisms, Regulation, and Roles of Mutationally Activated Gα in Human Cancer8
Table of Contents8
β-Caryophyllene Inhibits Monoacylglycerol Lipase Activity and Increases 2-Arachidonoyl Glycerol Levels In Vivo: A New Mechanism of Endocannabinoid-Mediated Analgesia?8
Predicting compounds that interact with the 2 known agonist-induced conformations of the human β1-adrenoceptor8
Table of Contents7
Corrigendum to “Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2- Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesio7
The Glycosylated N-Terminal Domain of MUC1 Is Involved in Chemoresistance by Modulating Drug Permeation Across the Plasma Membrane7
A Novel Role of Uricosuric Agent Benzbromarone in BK Channel Activation and Reduction of Airway Smooth Muscle Contraction7
Development of an LC-MS/MS Method to Measure Sphingolipids in CSF from Patients with Multiple Sclerosis7
Corrigendum to “The Natural Compound Withaferin A Covalently Binds to Cys239 of β-Tubulin to Promote Tubulin Degradation”7
The M3 Muscarinic Acetylcholine Receptor Can Signal through Multiple G Protein Families7
Editorial Board7
GRK2 and GRK5—The 2 critical kinases in cardiac pathophysiology7
Induced Fit Describes Ligand Binding to Membrane-Associated Cytochrome P450 3A47
Promotion of Tumor Cell Senescence by the Antibody–Drug Conjugate, Sacituzumab Govitecan7
Cepharanthine, a valuable sanative alternative for hepatocellular carcinoma through regulating Hippo-Yes-associated protein signal transduction6
Insights Into the Differential Desensitization of α4β2 Nicotinic Acetylcholine Receptor Isoforms Obtained With Positive Allosteric Modulation of Mutant Receptors6
Pharmacological Targeting of Senescence with Senolytics as a New Therapeutic Strategy for Neurodegeneration6
Activation of TRPV3 channels in bladder cancer cells stimulates ATP release6
Inhibition of Cardiac Kv4.3/KChIP2 Channels by Sulfonylurea Drug Gliquidone6
Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR36
Elucidating the binding and metabolic interactions of sunitinib and sorafenib with Cytochrome P450s CYP2U1 and CYP2D66
Upregulating vascular endothelial KCa2.3 channels alleviates pulmonary hypertension in mice6
Elucidating molecular mechanisms governing tumor necrosis factor-alpha–mediated regulation of amyloid beta 42 uptake in blood-brain barrier endothelial cells6
Circumvention of Topoisomerase IIα Intron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells6
Fanning the Flames of Endoplasmic Reticulum (ER) Stress: Can Sphingolipid Metabolism Be Targeted to Enhance ER Stress–Associated Immunogenic Cell Death in Cancer?6
N-(4-Bromo-2,5-Dimethoxyphenethyl)-6-(4-Phenylbutoxy)Hexan-1-Amine (XOB): A Novel Phenylalkylamine Antagonist of Serotonin 2A Receptors and Voltage-Gated Sodium Channels6
Loss of α-cell GRK2 modulates glucagon response and supports cardiac function6
Electrophysiological characterization of the state-dependent inhibition of Kv7.1 and IKs by UCL20776
The thiazolidinedione drug troglitazone inhibits Gq signaling through direct binding to the Gq alpha subunit through inhibition of GDP release6
Mechanisms of Action Underlying Conductance-Modifying Positive Allosteric Modulators of the NMDA Receptor5
Aryl Hydrocarbon Receptor as a Therapeutical Target of Environmentally Induced Skin Conditions5
Multiomics Analyses Identify Proline Endopeptidase–Like Protein As a Key Regulator of Protein Trafficking, a Pathway Underlying Alzheimer’s Disease Pathogenesis5
HDAC6 inhibition ameliorates sensory hypersensitivity and reduces immune cell signatures in the dorsal root ganglia in murine chronic pain models5
Editorial Board5
Molecular determinants of 2-aminoethoxydiphenyl borate sensitivity of transient receptor potential vanilloid 2-unexpected differences between 2 rodent orthologs5
Role of Mitochondrial and Cytosolic Folylpolyglutamate Synthetase in One-Carbon Metabolism and Antitumor Efficacy of Mitochondrial-Targeted Antifolates5
Drugs Form Ternary Complexes with Human Liver Fatty Acid Binding Protein 1 (FABP1) and FABP1 Binding Alters Drug Metabolism5
A Sentimental Segue5
Editorial Board5
Editorial Board5
Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood–Brain Barrier Endothelium5
The Common LncRNAs of Neuroinflammation-Related Diseases5
Table of Contents5
Expression of Ceramide Synthases in Mice and Their Roles in Regulating Acyl-Chain Sphingolipids: A Framework for Baseline Levels and Future Implications in Aging and Disease5
The CaMKII D135N mutation blocks kinase activity and reduces GluN2B binding4
Cannabinoid receptor 2 activating antibodies: A promising therapeutic strategy for macrophage-driven fibro-inflammatory diseases4
Table of Contents4
Ca2+/calmodulin-dependent inhibitors of adenylyl cyclase 1 as novel nonopioid analgesics for chronic inflammatory pain4
A Constitutive EGFR Kinase Dimer to Study Inhibitor Pharmacology4
Substituted Cysteine Modification and Protection with n-Alkyl-MTS Reagents Quantifies Steric Changes Induced by a Mutation in Anesthetic Binding Sites on GABA Type A Receptors4
Extrachromosomal Circular DNAs, Amplified Oncogenes, and CRISPR-Cas9 System4
Multiwalled carbon nanotubes activate the NLRP3 inflammasome-dependent pyroptosis in macrophages4
Table of Contents4
Correction to “Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo”4
State-Dependent Inhibition of Nav1.8 Sodium Channels by VX-150 and VX-5484
Interaction between W41 of the hepatitis B virus preS1 surface peptide and Y146/F274 of the cellular receptor molecule Na+/taurocholate co-transporting polypeptide is essential for virus entry4
Upacicalcet Is a Novel Secondary Hyperparathyroidism Drug that Targets the Amino Acid Binding Site of Calcium-Sensing Receptor4
Screening and Identification of a Novel Anti–Siglec-15 Human Antibody 3F1 and Relevant Antitumor Activity4
Corrigendum to “Repurposing Treprostinil for Enhancing Hematopoietic Progenitor Cell Transplantation”4
Dual nuclear receptor 4A1 (NR4A1/NR4A2) ligands inhibit glioblastoma growth and target TWIST14
Development of a Selective and High Affinity Radioligand, [3H]VU6013720, for the M4 Muscarinic Receptor4
Atypical Chemokine Receptor 3 “Senses” CXC Chemokine Receptor 4 Activation Through GPCR Kinase Phosphorylation4
Voltage sensor interaction site for a selective small molecule Nav1.1 sodium channel potentiator that enhances firing of fast-spiking interneurons4
Evaluation of allosteric N-methyl-d-aspartate receptor modulation by GluN2A-selective antagonists using pharmacological equilibrium modeling4
Editorial Board4
Differential Activity of Orthosteric Agonists and Allosteric Modulators at Metabotropic Glutamate Receptor 74
Effects of two structurally diverse positive allosteric modulators on signaling bias at the μ-opioid receptor4
Corrigendum to “Functional Interaction between Transient Receptor Potential V4 Channel and Neuronal Calcium Sensor 1 and the Effects of Paclitaxel”3
Transcriptional Regulation, Signaling Pathways, and Subcellular Localization of Corticotropin-Releasing Factor Receptors in the Central Nervous System3
Passive Immunotherapies Targeting Amyloid-β in Alzheimer’s Disease: A Quantitative Systems Pharmacology Perspective3
Ketamine and Major Ketamine Metabolites Function as Allosteric Modulators of Opioid Receptors3
Receptor Determinants for β-Arrestin Functional Specificity at C-X-C Chemokine Receptor 53
Molecular and cellular effects of hydroxy-1,4 naphthoquinones used in dermatological and cosmetic applications on human protein tyrosine phosphatase PTP1B in human keratinocytes3
Role of GPR55 in glutamatergic and dopaminergic signaling: A review of preclinical evidence in neuropsychiatric disorders3
Rare variant in intracellular loop-2 alters the spatial distribution and transducer coupling selectivity of the ghrelin receptor3
The peroxisome proliferator–activated receptor α/β/γ agonist NCPC-626 from microbial metabolites alleviates metabolic dysfunction–associated steatohepatitis in mice3
Chemokine receptors – Exemplifying functional divergence in G protein-coupled receptors3
AKAP6β – A Conductor in the Orchestra of Pathological Cardiomyocyte Gene Transcription3
Table of Contents3
Editorial Board3
Cyclovirobuxine inhibits ferroptosis to mitigate Alzheimer disease in glutamate-induced SH-SY5Y cell: the role of the liquid-liquid phase separation of FTH13
A machine learning–based analysis method for small molecule high content screening of three-dimensional cancer spheroid morphology3
The Small Molecule Antagonist KCI807 Disrupts Association of the Amino-Terminal Domain of the Androgen Receptor with ELK1 by Modulating the Adjacent DNA Binding Domain3
G protein-coupled receptor–targeted proteolysis-targeting chimeras in cancer therapeutics3
New Mechanisms Underlying Oncogenesis in Dbl Family Rho Guanine Nucleotide Exchange Factors3
Agonists of the Nuclear Receptor PPARγ Can Produce Biased Signaling3
Rescue of Familial Lecithin:Cholesterol Acyltranferase Deficiency Mutations with an Allosteric Activator3
Contents3
Alkannin Attenuates Amyloid β Aggregation and Alzheimer’s Disease Pathology3
Editorial Board2
Voltage sensors2
Corrigendum to “Amantadine derivative Amt-1 enhances antiviral defense against influenza A virus via Nrf2/HO-1 pathway” [Molecular Pharmacology 108 (2026) 100099]2
Therapeutic Potential for Metabotropic Glutamate Receptor 7 Modulators in Cognitive Disorders2
Correction to “Gossypetin Prevents the Progression of Nonalcoholic Steatohepatitis by Regulating Oxidative Stress and AMP-Activated Protein Kinase”2
Deorphanization of G Protein Coupled Receptors: A Historical Perspective2
Pharmacologic Characterization of LTGO-33, a Selective Small Molecule Inhibitor of the Voltage-Gated Sodium Channel NaV1.8 with a Unique Mechanism of Action2
Correction to “A Novel Semisynthetic Inhibitor of the FRB Domain of Mammalian Target of Rapamycin Blocks Proliferation and Triggers Apoptosis in Chemoresistant Prostate Cancer Cells”2
Effects of Small Molecule Ligands on ACKR3 Receptors2
Pirin does not bind to p65 or regulate NFκB-dependent gene expression but does modulate cellular quercetin levels2
Biasing Gβγ Downstream Signaling with Gallein Inhibits Development of Morphine Tolerance and Potentiates Morphine-Induced Nociception in a Tolerant State2
Comparative evaluation of the biological characteristics of a novel retinoid X receptor agonist and bexarotene2
Corrigendum to “Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effects” [Molecular Pharma2
Lubiprostone is a Non-Selective Activator of cAMP-Gated Ion Channels and Chloride Channel Protein 2 (Clc-2) Has a Minor Role in its Prosecretory Effect in Intestinal Epithelial Cells2
Table of Contents2
Signaling Specificity and Kinetics of the Human Metabotropic Glutamate Receptors2
Amiodarone irrecoverably impairs the function of human ether-a-go-go-related gene potassium channels2
Coexpressed δ-, μ-, and κ-Opioid Receptors Modulate Voltage-Gated Ca2+ Channels in Gastric-Projecting Vagal Afferent Neurons2
Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effects2
Pharmacological Characterization of the Zebrafish (Danio Rerio) Histamine H1 Receptor Reveals the Involvement of the Second Extracellular Loop in the Binding of Histamine2
Special Section on Therapeutic Implications for Sphingolipids in Health and Disease—Editorial2
Differential Effects of Remdesivir and Lumacaftor on Homomeric and Heteromeric hERG Channels2
Bioengineered miR-7-5p modulates non–small cell lung cancer cell metabolism to improve therapy1
Synergy between Interleukin-1β, Interferon-γ, and Glucocorticoids to Induce TLR2 Expression Involves NF-κB, STAT1, and the Glucocorticoid Receptor1
Mice carrying the human dopamine D2 receptor pathogenic mutation p.Met374Arg exhibit hyperactivity and aberrant D2 receptor function1
Editorial Board1
Discovery and Characterization of VU0542270, the First Selective Inhibitor of Vascular Kir6.1/SUR2B KATP Channels1
The Potential Antidepressant Compound Org 34167 Modulates HCN Channels Via a Novel Mode of Action1
Introduction of a single carboxylic acid converts the cyclic oligomeric depsipeptide ent-verticilide from a ryanodine receptor 2 (RyR2) inhibitor to RyR2 activator1
Ion channels and G protein-coupled receptors: Cannabidiol actions on disorders of excitability and synaptic excitatory-inhibitory ratio1
Extracellular ATP increases agonist potency and reduces latency at class B G protein-coupled receptors1
Table of Contents1
Inhibition of Tumor-Derived C-C Motif Chemokine Ligand 2 Expression Attenuates Tactile Allodynia in NCTC 2472 Fibrosarcoma-Inoculated Mice1
Editorial Board1
Protein Kinases and Cross-talk between Post-translational Modifications in the Regulation of Drug Transporters1
Transient receptor potential vanilloid 3 activation accelerates keratinocyte migration in vitro but not dermal wound healing in vivo1
Table of Contents1
Design and evaluation of highly selective histone deacetylase 6 inhibitors derived from the natural product tryptoline1
Allosteric Inhibition and Pharmacochaperoning of the Serotonin Transporter by the Antidepressant Drugs Trazodone and Nefazodone1
Inhibition of the Aromatase Enzyme by Exemestane Cysteine Conjugates1
Mechanisms for enhancement of μ-opioid receptor-mediated antinociception in the central nervous system through gallein-dependent modulation of downstream G protein βγ subunit signaling1
Pharmacological characterization of a clinical candidate, TG-0054, a small molecule inverse agonist targeting CXCR41
Editorial Board1
Emerging voices in G protein-coupled receptor biology1
Inhibitory Actions of Potentiating Neuroactive Steroids in the Human α1β3γ2L γ-Aminobutyric Acid Type A Receptor1
Table of Contents1
Editorial Board1
AKAP-scaffolded complexes and cyclic AMP signaling within the dorsal root ganglia in chronic pain1
Liver CYP4A autophagic lysosomal degradation: A major role for the autophagic receptor SQSTM1/p62 through an uncommon target interaction site1
Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring1
Expression of concern: “The Cyclopentenone Prostaglandin 15-Deoxy-delta12,14-Prostaglandin J2 Attenuates the Development of Acute and Chronic Inflammation” [Mol. Pharmacol. 2002; 61: 997-1007] by Cuzz1
Intracellular Allosteric Antagonist of the Olfactory Receptor OR51E21
Determinants of Subtype-Selectivity of the Anthelmintic Paraherquamide A on Caenorhabditis elegans Nicotinic Acetylcholine Receptors1
Functional Assessment of Cancer-Linked Mutations in Sensitive Regions of Regulators of G Protein Signaling Predicted by Three-Dimensional Missense Tolerance Ratio Analysis1
Perspective: Therapeutic Implications for Sphingolipids in Health and Disease1
0.21938300132751